OpenURL Connection Search

Select item for more details and to access through your institution.

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P81, doi. 10.1186/1758-2652-13-S4-P81
By:
- Podzamczer, D;
- Tiraboschi, JM;
- Mallolas, J;
- Cárdenes, MA;
- Casas, E;
- Castro, A;
- Echevarria, S;
- Leal, M;
- Bernanldo de Quirós, JC Lopez;
- Moreno, S;
- Puig, T;
- Ribera, E;
- Villalonga, C;
- Gomez Sirvent, JL;
- Garcia Heranejos, JA;
- Lopez-Aldeguer, J;
- Barrufet, P;
- Force, L;
- Santos, I;
- Sanz, J
Publication type:
Article
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations.
Published in:
HIV Medicine, 2021, v. 22, n. 7, p. 581, doi. 10.1111/hiv.13093
By:
- Saumoy, M;
- Di Yacovo, S;
- Pérez, S;
- Sánchez‐Quesada, JL;
- Valdivielso, JM;
- Subirana, I;
- Imaz, A;
- Tiraboschi, JM;
- García, B;
- Ordoñez‐LLanos, J;
- Benítez, S;
- Podzamczer, D;
- Grau, M
Publication type:
Article
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Published in:
HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243
By:
- Tiraboschi, JM;
- Muñoz‐Moreno, JA;
- Puertas, MC;
- Alonso‐Villaverde, C;
- Prats, A;
- Ferrer, E;
- Rozas, N;
- Maso, M;
- Ouchi, D;
- Martinez‐Picado, J;
- Podzamczer, D
Publication type:
Article
Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)
Published in:
2011
By:
- Saumoy, M;
- Tiraboschi, Jm;
- Gutierrez, M;
- Niubó, J;
- Domingo, P;
- Vila, A;
- Podzamczer, D
Publication type:
Journal Article

Found: 4

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years.

Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations.

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.

Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)